Aberdeen Group Portfolio holdings
Aberdeen Group is a British wealth and investment company, created in 2017 when Standard Life merged with Aberdeen Asset Management. In 2018 it agreed to sell the Standard Life insurance business to Phoenix Group, shifting the company from insurance toward asset management. After selling the Standard Life name to Phoenix Group in 2021 it rebranded as abrdn, a vowel-free name that drew criticism, and in 2025 it went back to Aberdeen. Among its businesses is Interactive Investor, a British retail investing service that runs on subscriptions, which it bought in 2022.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$319M |
| 2 |
Amazon
AMZN
|
+$165M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$92.7M |
| 5 |
UnitedHealth
UNH
|
+$69.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$182M |
| 2 |
RTX Corp
RTX
|
+$97.9M |
| 3 |
Marvell Technology
MRVL
|
+$81.2M |
| 4 |
GE Vernova
GEV
|
+$80.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Healthcare | 12.68% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 10.76% |
| 5 | Financials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
576
PTC
PTC
$21.2B
| $11M | 0.02% |
96,831
-11,209
| -10% | -$1.51M |
2018 Q4
30 quarters
|
|
577
AgomAb Therapeutics NV
AGMB
$369M
| $11M | 0.02% |
846,695
+139,039
| +20% | +$1.57M |
2026 Q1
1 quarter
|
|
578
SpyGlass Pharma
SGP
$1.08B
| $11M | 0.02% |
493,076
+272,622
| +124% | +$5.91M |
2026 Q1
1 quarter
|
|
579
Comfort Systems
FIX
$43.4B
| $10.9M | 0.02% |
5,508
+477
| +9% | +$866K |
2025 Q4
2 quarters
|
|
580
DTE Energy
DTE
$28.2B
| $10.8M | 0.02% |
70,590
-29,562
| -30% | -$4.32M |
2017 Q3
35 quarters
|
|
581
Genuine Parts
GPC
$16.7B
| $10.7M | 0.02% |
90,871
+6,779
| +8% | +$708K |
2017 Q3
35 quarters
|
|
582
NiSource
NI
$21.4B
| $10.7M | 0.02% |
225,142
-237,718
| -51% | -$11.2M |
2017 Q3
35 quarters
|
|
583
Nebius Group N.V.
NBIS
$41.9B
| $10.6M | 0.01% |
38,467
+9,295
| +32% | +$1.84M |
2017 Q3
35 quarters
|
|
584
Loma Negra
LOMA
$1.07B
| $10.6M | 0.01% |
925,591
+11,700
| +1% | +$133K |
2018 Q2
32 quarters
|
|
585
Rhythm Pharmaceuticals
RYTM
$6.37B
| $10.5M | 0.01% |
94,946
+15,589
| +20% | +$1.41M |
2026 Q1
1 quarter
|
|
586
Allogene Therapeutics
ALLO
$408M
| $10.4M | 0.01% |
5,001,752
+3,539,533
| +242% | +$7.77M |
2024 Q4
6 quarters
|
|
587
Altria Group
MO
$130B
| $10.3M | 0.01% |
143,634
-46,406
| -24% | -$3.24M |
2017 Q3
35 quarters
|
|
588
Alphatec Holdings
ATEC
$1.08B
| $10.3M | 0.01% |
1,188,581
-104,025
| -8% | -$948K |
2023 Q2
12 quarters
|
|
589
GE HealthCare
GEHC
$34.6B
| $10.2M | 0.01% |
160,080
-177,318
| -53% | -$11.7M |
2023 Q1
13 quarters
|
|
590
Sociedad Química y Minera de Chile
SQM
$15.6B
| $10.2M | 0.01% |
138,339
-110,762
| -44% | -$9.28M |
2017 Q4
34 quarters
|
|
591
TransUnion
TRU
$14.6B
| $10.2M | 0.01% |
141,151
+2,095
| +2% | +$147K |
2018 Q2
32 quarters
|
|
592
Packaging Corp of America
PKG
$22.9B
| $10.2M | 0.01% |
42,701
+196
| +0.5% | +$43K |
2017 Q3
35 quarters
|
|
593
Cytokinetics
CYTK
$8.76B
| $10.2M | 0.01% |
119,435
-363,839
| -75% | -$26.1M |
2023 Q4
10 quarters
|
|
594
Alkermes
ALKS
$7.61B
| $10.2M | 0.01% |
+193,805
| New | +$7.57M |
2026 Q2
0 quarters
|
|
595
Corporacion America
CAAP
$3.88B
| $10.1M | 0.01% |
401,465
+4,500
| +1% | +$116K |
2018 Q2
32 quarters
|
|
596
Zscaler
ZS
$38.8B
| $10.1M | 0.01% |
71,337
+4,111
| +6% | +$573K |
2020 Q3
23 quarters
|
|
597
Gen Digital
GEN
$17.3B
| $10M | 0.01% |
400,207
+5,127
| +1% | +$115K |
2017 Q3
35 quarters
|
|
598
Spire
SR
$5.2B
| $9.9M | 0.01% |
+127,100
| New | +$10.9M |
2026 Q2
0 quarters
|
|
599
Banco Santander Chile
BSAC
$14.4B
| $9.9M | 0.01% |
301,031
-36,812
| -11% | -$1.19M |
2017 Q3
35 quarters
|
|
600
Shattuck Labs
STTK
$558M
| $9.8M | 0.01% |
1,405,851
+246,530
| +21% | +$1.54M |
2025 Q3
3 quarters
|
|
Similar funds
Aberdeen Group's Q2 2026 Portfolio in Review
As of Q2 2026, Aberdeen Group held 978 positions worth $71.2B, up 15% from $61.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Aberdeen Group's Q2 2026 filing shows 47 new, 453 increased, 412 reduced and 44 closed positions. Its largest new stake was Honeywell Aerospace: 420,093 shares worth $92.9M. The largest sale was Honeywell, an estimated $182M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Aberdeen Group's largest Q2 2026 buy was Honeywell Aerospace: 420,093 shares worth $92.9M.
- Aberdeen Group added most to Tesla in Q2 2026, an estimated $319M increase.
- Aberdeen Group's biggest Q2 2026 reduction was RTX Corp, cutting an estimated $97.9M.
- Aberdeen Group fully exited Honeywell in Q2 2026, selling an estimated $182M.
- Aberdeen Group's ten largest holdings make up 37% of its $71.2B portfolio in Q2 2026.
- Aberdeen Group opened 47 new positions and closed 44 in Q2 2026.
- Aberdeen Group's portfolio value rose 15% quarter-over-quarter to $71.2B.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.